Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Lisata Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q2 2023
- Shares held
- 684.8K
- +4.00K (+0.6%) vs. Q2 2023
- Total value
- $1.46M
- −$1.05M (−41.9%) vs. Q2 2023
- New holders
- 3
- 8 more added
- Sold out
- 4
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $3.70M |
| Q1 2026 | 34 | $7.06M |
| Q4 2025 | 25 | $1.36M |
| Q3 2025 | 21 | $1.93M |
| Q2 2025 | 20 | $2.26M |
| Q1 2025 | 22 | $1.84M |
| Q4 2024 | 21 | $2.33M |
| Q3 2024 | 20 | $2.30M |
| Q2 2024 | 22 | $2.61M |
| Q1 2024 | 21 | $2.30M |
| Q4 2023 | 22 | $2.03M |
| Q3 2023 | 21 | $1.46M |
| Q2 2023 | 22 | $2.51M |
| Q1 2023 | 21 | $2.08M |
| Q4 2022 | 24 | $1.83M |
| Q3 2022 | 22 | $2.17M |
| Q2 2022 | 36 | $5.00M |
| Q1 2022 | 34 | $6.13M |
| Q4 2021 | 36 | $7.33M |
| Q3 2021 | 34 | $9.41M |
| Q2 2021 | 29 | $10.1M |
| Q1 2021 | 33 | $12.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 52 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $4 | 0.00% | +1+100.0% | Added |
| Barclays PLC | 4 | $9 | 0.00% | −23−85.2% | Reduced |
| Steward Partners Investment Advisory, LLC | 6 | $13 | 0.00% | +6 | New |
| JPMorgan Chase & Co | 8 | $17 | 0.00% | +8 | New |
| IFP Advisors, Inc | 10 | $21 | 0.00% | +10 | New |
| Northwestern Mutual Wealth Management Co | 20 | $43 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 49 | $105 | 0.00% | +18+58.1% | Added |
| UBS Group AG | 143 | $306 | 0.00% | +142+14,200.0% | Added |
| Founders Capital Management | 666 | $1.43K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,099 | $6.63K | 0.00% | −11,024−78.1% | Reduced |
| Bank of America Corp | 9,684 | $20.7K | 0.00% | +9,658+37,146.2% | Added |
| HighTower Advisors, LLC | 10,044 | $21.0K | 0.00% | +20.0% | Added |
| Cook Wealth Management Group LLC | 12,175 | $25.1K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 14,348 | $30.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,582 | $38.8K | 0.00% | +1,404+8.2% | Added |
| Geode Capital Management, LLC | 43,390 | $90.7K | 0.00% | +17,417+67.1% | Added |
| BlackRock Inc. | 56,806 | $121.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 95,722 | $205.0K | 0.00% | +2,400+2.6% | Added |
| Vanguard Group Inc | 176,139 | $376.9K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 243,839 | $521.8K | 0.48% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −14,951−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,060−100.0% | Sold out |
| Valley National Advisers Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |